Human VEGF165 Antibody
R&D Systems | Catalog # AB-293-NA
Loading...
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human, Mouse, Rat, Primate - Macaca mulatta (Rhesus Macaque), Rabbit, Xenograft
Applications
Validated:
Immunohistochemistry, Western Blot, Neutralization
Cited:
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Neutralization, Bioassay, Complex Application, ELISA Development
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Loading...
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGF165
Ala27-Arg191
Accession # AAV38412
Ala27-Arg191
Accession # AAV38412
Specificity
Detects human VEGF
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Scientific Data Images for Human VEGF165 Antibody
VEGF165in Human Breast Cancer Tissue.
VEGF165was detected in immersion fixed frozen sections of human breast cancer tissue using 5 µg/mL Human VEGF165Polyclonal Antibody (Catalog # AB‑293‑NA) overnight at 4 °C. Tissue was stained (red) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.Cell Proliferation Induced by VEGF165and Neutralization by Human VEGF Antibody.
Recombinant Human VEGF165(Catalog # 293-VE) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human VEGF165(10 ng/mL) is neutralized (green line) by increasing concentrations of Human VEGF 165 Polyclonal Antibody (Catalog # AB-293-NA). The ND50 is typically 0.600-7.20 µg/mL.VEGF in Human Breast Cancer Tissue.
VEGF was detected in immersion fixed paraffin-embedded sections of human breast cancer tissue using Human VEGF 165 Polyclonal Antibody (Catalog # AB-293-NA) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). Lower panel shows a lack of labeling if primary antibodies are omitted and tissue is stained only with secondary antibody followed by incubation with detection reagents. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.Detection of VEGF165 by Immunohistochemistry
The intracellular relocation of PHB was induced by vascular endothelial growth factor (VEGF) in CRC (A) Stromal were mixed with LS174T or SW480 or SW620 & were cultured for 24 h. Supernatants were collected & VEGF levels were determined using the enzyme-linked immune sorbent assay (ELISA). *P < 0.01, **P < 0.001. Data are shown as means ± SD. Levels of VEGF expression in the interstitial tissue are shown in primary CRC with metastasis & non-metastasis. *P < 0.001. Data are shown as means ± SEM. (B) Quantitative analysis of wound-healing assays was performed by calculating the percentage of in which PHB was relocated to the direction of wound. *P < 0.01 & **P < 0.001. Data are shown as means ± SD. (C) A schematic model & an experimental example for the polarized migration assay. A mixture of VEGF & Matrigel was placed in area 1, Matrigel alone was placed in area 2, 3, & 4, & the in area 5 were chosen for polarization analysis. in which PHB was located within the 120° angle were counted as being in the direction of VEGF stimulation, & are marked as red stars. The quantitative analysis of polarity assays was performed by calculation of the percentage of in which PHB was relocated to the direction of VEGF stimulation. *P < 0.001 compared with VEGF treatment for 0 h. Data are shown as means ± SD. (D) Co-immunoprecipitation assay with Cdc42. Cdc42 & PHB were expressed in SW480/LS174T with (+) or without (-) VEGF (100 ng/mL) treatment for 24 h. (E) Indicated GST-fusion proteins were incubated with lysates from SW480/LS174T & precipitated with glutathione beads. PHB was detected in the eluates of GST-Cdc42. (F) Co-immunostaining for PHB & Cdc42 in SW480/LS174T with or without VEGF stimulation. The arrowheads indicate PHB & Cdc42 directionality. Scale bars: 10 μm. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29100316), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human VEGF165 Antibody
Application
Recommended Usage
Immunohistochemistry
5-15 µg/mL
Sample: Immersion fixed frozen or paraffin-embedded sections of human breast cancer tissue
Sample: Immersion fixed frozen or paraffin-embedded sections of human breast cancer tissue
Western Blot
1 µg/mL
Sample: Recombinant Human VEGF165 (Catalog # 293-VE)
Sample: Recombinant Human VEGF165 (Catalog # 293-VE)
Neutralization
Measured by its ability to neutralize VEGF165-induced proliferation in HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci USA 87:1323. The Neutralization Dose (ND50) is typically 0.600-7.20 µg/mL in the presence of 10 ng/mL Recombinant Human VEGF165.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Reconstitution
Reconstitute at 1 mg/mL in sterile PBS.
Loading...
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: VEGF
Long Name
Vascular Endothelial Growth Factor
Alternate Names
MVCD1, VAS, Vasculotropin, VEGF-A, VEGFA, VPF
Entrez Gene IDs
Gene Symbol
VEGFA
UniProt
Additional VEGF Products
Product Documents for Human VEGF165 Antibody
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human VEGF165 Antibody
For research use only
Citations for Human VEGF165 Antibody
Customer Reviews for Human VEGF165 Antibody
There are currently no reviews for this product. Be the first to review Human VEGF165 Antibody and earn rewards!
Have you used Human VEGF165 Antibody?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- ClariTSA™ Fluorophore Kits
- Detection & Visualization of Antibody Binding
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars
Loading...